Sacha Loiseau

Sacha Loiseau, Ph.D., is President, CEO and Co-Founder of Mauna Kea Technologies. Dr. Loiseau founded Mauna Kea Technologies in May 2000 and has been the CEO ever since. A co-inventor of the probe-based Confocal Laser Endomicroscopy technology,  he piloted the development of the Cellvizio product line, raising over 32 million euros with private investors until taking the company public in July 2011 on the NYSE Euronext Paris stock exchange. Mauna Kea’s IPO enabled a capital raise of 56.5 million euros with new investors only and was the largest health care IPO in Europe in 2011. In 2013, Dr. Loiseau was named the co-lead of France’s reindustrialization plan for medical devices by the French President and then a member of the Committee for the Future of Medicine. Dr. Loiseau started his career at the National Center for Space Studies in Toulouse and at the Paris Observatory, then joined NASA’s Jet Propulsion Laboratory in Pasadena, California, as a research scientist. He is a graduate of the Ecole Polytechnique in Paris and has a Ph.D. in astrophysics and optical instrumentation. Dr. Loiseau is the author of multiple scientific articles and holds seven international patents.